TrianglePUBLICATIONS · 22836511
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Cancer
- Publication date
- 2012 Aug 7
- First author
- Wagner U
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Wagner U
- type
- Author
- name
- Marth C
- type
- Author
- name
- Largillier R
- type
- Author
- name
- Kaern J
- type
- Author
- name
- Brown C
- type
- Author
- name
- Heywood M
- type
- Author
- name
- Bonaventura T
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Piccirillo MC
- type
- Author
- name
- Fossati R
- type
- Author
- name
- Gebski V
- type
- Author
- name
- Lauraine EP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Wagner U
- type
- Author
- name
- Marth C
- type
- Author
- name
- Largillier R
- type
- Author
- name
- Kaern J
- type
- Author
- name
- Brown C
- type
- Author
- name
- Heywood M
- type
- Author
- name
- Bonaventura T
- type
- Author
- name
- Vergote I
- type
- Author
- name
- Piccirillo MC
- type
- Author
- name
- Fossati R
- type
- Author
- name
- Gebski V
- type
- Author
- name
- Lauraine EP
- type
- Author
- bibliography ids
- nci-bib-1d824c636a2cb9f119749df0
- book metadata
- content sha256
- 3eec8a49411089e99897469d1ac58f0c287277b7357fe7b6c6740cbb73d71557
- document type
- citation
- dois
- 10.1038/bjc.2012.307
- electronic publication date
- display
- 2012 Jul 26
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22836511
- immutable id
- pubmed:22836511@3eec8a49411089e99897469d1ac58f0c287277b7357fe7b6c6740cbb73d71557
- journal
- abbreviation
- Br J Cancer
- issn electronic
- 1532-1827
- issn print
- 0007-0920
- issue
- 4
- name
- British journal of cancer
- nlm unique id
- 0370635
- pages
- 588-91
- volume
- 107
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22836511
- provenance
- batch id
- 1e3045de9f47a5ccd566
- provider
- NCBI PubMed ESummary
- record sha256
- 56cda6b8eb5b284c9ba1db861964c95db2d520f5645ae23f597118017b02093a
- response sha256
- 0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
- retrieved at
- 2026-09-09T23:46:50.128287+00:00
- publication date
- display
- 2012 Aug 7
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients.
Preserved source evidence · Not medical advice